GBM AGILE
Phase 2/3 Recruiting
2,250 enrolled
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Phase 2/3 Recruiting
156 enrolled
Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.
Phase 2/3 Recruiting
160 enrolled
Eliminate
Phase 2/3 Recruiting
396 enrolled
SHAPE Neoadjuvant Chemotherapy Response
Phase 2/3 Recruiting
200 enrolled
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
Phase 2/3 Recruiting
400 enrolled
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Phase 2/3 Recruiting
686 enrolled
CIRCULATE-US
Phase 2/3 Recruiting
1,912 enrolled
STARS-RC10
Phase 2/3 Recruiting
212 enrolled
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Phase 2/3 Recruiting
60 enrolled
PRO-BOOST-LC
Phase 2/3 Recruiting
1,200 enrolled
PRO-BOOST-N
Phase 2/3 Recruiting
1,600 enrolled
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
Phase 2/3 Recruiting
200 enrolled
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 2/3 Recruiting
308 enrolled
THUNDER
Phase 2/3 Recruiting
493 enrolled
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Phase 2/3 Recruiting
225 enrolled
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
Phase 2/3 Recruiting
40 enrolled
DIREKHT2
Phase 2/3 Recruiting
508 enrolled
FEMUS
Phase 2/3 Recruiting
260 enrolled
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
Phase 2/3 Recruiting
150 enrolled
NEOASIS
Phase 2/3 Recruiting
133 enrolled
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
Phase 2/3 Recruiting
60 enrolled
EMPTY
Phase 2/3 Recruiting
170 enrolled
Glo-BNHL
Phase 2/3 Recruiting
210 enrolled
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
Phase 2/3 Recruiting
324 enrolled
Morpheus
Phase 2/3 Recruiting
131 enrolled
PANACHE 02
Phase 2/3 Recruiting
390 enrolled
GRAALL-2024
Phase 2/3 Recruiting
1,200 enrolled
GRECCAR14
Phase 2/3 Recruiting
1,075 enrolled
A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma
Phase 2/3 Recruiting
40 enrolled
ALICE
Phase 2/3 Recruiting
196 enrolled
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
Phase 2/3 Recruiting
30 enrolled
Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer
Phase 2/3 Recruiting
53 enrolled
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Phase 2/3 Recruiting
64 enrolled
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
Phase 2/3 Recruiting
375 enrolled
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Phase 2/3 Recruiting
300 enrolled
AFGB2
Phase 2/3 Recruiting
300 enrolled
DEXTER
Phase 2/3 Recruiting
80 enrolled
Contrast-enhanced Ultrasound for Sentinel Node Detection
Phase 2/3 Recruiting
91 enrolled
Extended-field Proton Therapy for Cervical Cancer
Phase 2/3 Recruiting
44 enrolled
ROCSAN
Phase 2/3 Recruiting
138 enrolled
4-aminopyridine Treatment for Nerve Injury
Phase 2/3 Recruiting
70 enrolled
ABATE-MASLD
Phase 2/3 Recruiting
20 enrolled
Trop2-targeted immunoPET Imaging of Solid Tumors
Phase 2/3 Recruiting
400 enrolled
PLATINUM-CAN
Phase 2/3 Recruiting
10 enrolled
Psilocybin Therapy in Advanced Cancer
Phase 2/3 Recruiting
200 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
RETINO 2018
Phase 2/3 Recruiting
225 enrolled
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
Phase 2/3 Recruiting
200 enrolled
Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma
Phase 2/3 Recruiting
80 enrolled